Avicenna (980-1037 CE) and his Early Description and Classification of Dementia.

Alzheimer’s disease Avicenna Persian medicine dementia history of medicine

Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2019
Historique:
pubmed: 17 9 2019
medline: 11 11 2020
entrez: 17 9 2019
Statut: ppublish

Résumé

According to the World Health Organization (WHO), dementia is a disorder that occurs as result of a neurodegenerative process in brain, and usually is chronic or progressive by nature. Most descriptions of senile dementia date back to Alois Alzheimer. In 1906, Alzheimer described the first patient, Auguste Deter, who suffered from the disorder that later became known as Alzheimer's disease. Although, the history of the disease before 1906 is quite rich, little has been said about the contributions of ancient and medieval physicians to the understanding of dementia. Over the centuries, the concept of senile dementia changed from an inevitable mental decline with aging, to different sets of clinical features with narrow limits of diagnosis of a disease in its own right. Documentation of the historical origins of prevention, diagnosis, and therapies of dementia would make an important contribution to a more complete understanding of this pathological degeneration of dementia. The present review focuses on the contributions of Avicenna (AD 980-1037) to the development of diagnosis and the discovery of etiology of different forms of dementia, with the goal of revealing the extent to which dementia was understood in the golden age of Islam in Persia.

Identifiants

pubmed: 31524162
pii: JAD190345
doi: 10.3233/JAD-190345
doi:

Types de publication

Historical Article Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1093-1098

Auteurs

Somaiyeh Taheri-Targhi (S)

Aging Research Institute, Tabriz University of Medical Science, Tabriz, Iran.

Albert Gjedde (A)

Department of Clinical Medicine, University of Southern Denmark, Odense, Denmark.
Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.

Mostafa Araj-Khodaei (M)

Aging Research Institute, Tabriz University of Medical Science, Tabriz, Iran.
Department of Persian Medicine, Faculty of Traditional Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Reza Rikhtegar (R)

Aging Research Institute, Tabriz University of Medical Science, Tabriz, Iran.

Zahra Parsian (Z)

Emergency Medicine Research Team, Tabriz University of Medical Sciences, Tabriz, Iran.

Sina Zarrintan (S)

Division of Vascular & Endovascular Surgery, Department of General & Vascular Surgery, Shohada-Tajrish Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mohammadali Torbati (M)

Department of Food Science and Technology, Faculty of nutrition, Tabriz University of Medical Sciences, Tabriz, Iran.

Manouchehr Seyedi Vafaee (MS)

Department of Clinical Medicine, University of Southern Denmark, Odense, Denmark.
Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Department of Psychiatry, Odense University Hospital, Odense, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH